Growth Warrior Capital

Investment decisions are led by Promise Phelon, the firm's founder and managing partner. Phelon brings direct operating experience as a multiple-time founder and CEO in the technology sector, including a notable exit, which shapes her approach to evaluating early-stage companies. The firm's public materials indicate she operates as the key decision-maker, consistent with a solo GP structure.

The firm focuses on 'resilience technology' — companies building tools and platforms that strengthen individual and organizational stamina. This encompasses workforce wellness, mental health infrastructure, productivity software, and human-performance solutions. Phelon's thesis is that founders who have overcome structural barriers have a distinct adaptive capability that translates into defensible business-building skills.

The firm's disclosed activity is concentrated on direct seed and start-up stage investments. There is no public evidence of fund-of-funds commitments, SPV-led syndicates, or secondary market participation. Growth Warrior Capital appears to operate as a pure-play direct investor backing companies at the earliest stages of formation.

No formal sector exclusions are publicly listed. However, the firm's resilience-tech framing steers it away from capital-intensive industries like hardware, deep tech, or life sciences that require long R&D gestation and have limited overlap with human performance or workplace productivity themes. Its generalist structure does not indicate commitment to any single vertical, but the thesis creates a natural filter.

The firm invests at the earliest stages — Seed and Start-up rounds. This aligns with Phelon's operator-first approach, where she engages founders before institutional Series A dynamics take hold. The fund's size and solo-GP structure are well-suited to leading or participating in pre-seed and seed rounds where personal conviction and founder rapport matter most.